Women In Steady Exercise Research - Neoadjuvant Exercise Trial

Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (AMIE = Addressing Metastatic Individuals Everyday)

Impact of Prehabilitation in Oncology Via Exercise - Breast Cancer

Communication Preferences Related to Over Screening for Cancer Among Older Adults

Exercise in Radiation Therapy (EXERT)

Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography

Phase II Palbociclib with Fulvestrant in Individuals with Hormone Receptive Positive HER2 Negative Metastatic Breast Cancer who progressed on treatment with Palbociclib + an Aromatase Inhibitor

CUFF Study: Characterization of Upper Limb Function following Mastectomy and Reconstruction for Breast Cancer

Physical Activity Training in Adolescents and Young Adults with Cancer: A Feasibility Study

Using Exercise to Improve Arthralgia and AI Adherence in Older Breast Cancer Survivors

Self-sampling for cancer tests among women in PA: Focus groups

Tomosynthesis Mammographic Imaging Screening Trial (TMIST)

The Effects of Inhaled Aromatherapy on Chemotherapy Induced Nausea and Vomiting (CINV) in Men and Women with Breast Cancer

Diminish Chemotherapy Related Side Effects through Patient Education

The COVID-19 and Cancer Consortium (CCC19) Registry

NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study

EA1181 (CompassHER2-pCR): Preoperative THP and postoperative HP in patients who achieve a pathologic complete response Part 1 Component of:The CompassHER2 Trials (COMprehensive use of Pathologic response Assessment to optimize therapy in HER2-positive breast cancer).

A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

A Phase II, Single Arm, Non-randomized Study of Alpelisib (BYL719) in Combination with Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer Big Ten Cancer Research Consortium BTCRC-BRE19-409

Nurse AMIE 3.0: Aim 1

Trial Assessing Light-Intensity Exercise on the Health of Older Breast Cancer Survivors (TALIE-HO Breast Cancer Survivors)

NRG-BR007: A Phase III Clinical Trial Evaluating Deescalation of Breast Radiation for Conservative Treatment of Stage I, Hormone sensitive, HER2- Negative Oncotype recurrence Score ≤ 18 Breast Cancer

COVID-19 Vaccination in Cancer Patients COVID-19 Vaccination Behavior and Outcomes in Cancer Patients

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Clinicopathologic Study of Breast Cancer

Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology